Vysis 06N38-020
Vysis 06N38-020 is a medical device (FDA Class II; FDA product code OWE) made by Abbott Molecular, approved under FDA PMA P110012 on 26 Aug 2011 and listed in FDA GUDID since 20 Nov 2014 (UDI-DI 00884999025745), active as of 23 Oct 2026.
Active
PMA
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00884999025745 | Date20 Nov 2014 | StatusListed |
| United States | FDA PMAAPPR | NumberP110012 | Date26 Aug 2011 | StatusActive |
Official records
- AccessGUDID record 00884999025745
- FDA PMA database P110012
From the FDA record
- Device description
- Vysis ALK Break Apart FISH Probe Kit
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA PMA P110012 decided 26 Aug 2011 Active
- FDA GUDID UDI-DI 00884999025745 listed 20 Nov 2014 Listed
Timeline
- Approved FDA PMA P110012
- Listed FDA GUDID 00884999025745
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- Vysis
- Generic name
- Anaplastic lymphoma kinase (ALK) genetic mutation IVD, probe
- Model / Ref / Catalog
- 06N38-020
- Primary DI / UDI-DI
- 00884999025745
- PMA number
- FDA product code
- OWE
- GMDN term
- Anaplastic lymphoma kinase (ALK) genetic mutation IVD, probe
- Device class
- Class II
- Regulation number
- 864.1890
- GUDID distribution status
- In Commercial Distribution